Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3

Clinical trial NCT03102606 · COMPLETED

Trial details

NCT number: NCT03102606
Sponsor: BeyondSpring Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2018-05-29
Primary completion: 2018-12-12
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.